Ranbaxy | PharmaTutor

15 September 2014

MITOMYCIN C: A USEFUL ANTICANCER DRUG

ABOUT AUTHOR:
Amitava Sinha Ray
Ranbaxy Laboratories Ltd
West Bengal, India
a.amitava.s@gmail.com

ABSTRACT
Cancer is basically a disease of cells characterized by a shift in the control mechanism which is associated with cell differentiation. In most cases causes of cancer is multifactorial. Cancer is the second most causes of death after heart disease. Cytotoxic chemotherapy for cancer offers cure for only certain type of cancer. Chemotherapy may prolong the life. Chemotherapy provides palliative rather than curative therapy at present.

31 August 2014

HEPARIN: POWERFUL AND INSTANTANEOUSLY ACTING ANTICOAGULANT

{ DOWNLOAD AS PDF }

ABOUT AUTHOR
Amitava Sinha Ray
Ranbaxy Laboratories Ltd
West Bengal, India
a.amitava.s@gmail.com

ABSTRACT
Anticoagulantis an agent that is used to prevent the formation of blood clots. Anticoagulants, such as heparin or warfarin work on chemical reactions in the body to lengthen the time it takes to form a blood clot. Heparin the anticoagulant drug that is used to prevent blood clots from forming during and after surgery and to treat various heart, lung, and circulatory disorders in human body. Heparin is comparatively a strong acid that forms water–soluble salts. It is used in treatment of venous thrombosis and its extensions, pulmonary embolism (PE), peripheral arterial embolism. Smoking and alcohol may alter response to heparin. Abrupt withdrawal of heparin may precipitate increased coagulability.

11 August 2014

SNAKE BITE ITS FIRST AID & ANTI SNAKE VENOM (ASV): DETAILS GUIDELINES

{ DOWNLOAD AS PDF }

ABOUT AUTHOR:
Amitava Sinha Ray
B.Pharmacy, DPM
RANBAXY LABORATORIES LTD.
West Bengal, India
a.amitava.s@gmail.com

ABSTRACT:
Snakebite is an injury caused by a bite from a snake. It can be dangerous and life threatening if the snake will venomous. India is the top country having the highest no. of death due to snake bite. Some specific venomous snake is responsible for this death. Till now people are not serious about that. Most of the people don’t know just the first aid of snake bite. After a snake bite most village people are going to unqualified person and quacks for treatment not to hospital, this is one of the most serious causes of death. People should be aware about the sign and symptoms of snake bite and at least the first aid treatment of snakebite. In this type of emergency victim should be admit to nearest hospital and Anti Snake Venom (ASV) is very much necessary to save the patient life.

23 July 2014

DIABETIC FOOT ULCER: A SERIOUS PROBLEM FOR DIABETIC PATIENT

{ DOWNLOAD AS PDF }

ABOUT AUTHOR:
Amitava Sinha Ray
RANBAXY LABORATORIES LTD.
West Bengal, India
a.amitava.s@gmail.com

ABSTRACT:
Diabetes is a major problem across the world also it is a serious problem in India. Diabetes Mellitus is a silent killer of human body. Several types of complication are occurred in diabetic patient. One of the serious complications is Diabetic foot ulcer. Generally occurred due to breakdown in the skinand subcutaneous tissue also muscle. It will be more dangerous if it will become infected. Sometimes it is also needed to cut down the leg by surgery to prevent the spread of infection. A diabetic patient should take care for his foot to avoid this type of complication, also should be more care full to the management of blood sugar in normal level.

11 May 2014

RANBAXY SCIENCE SCHOLARS-2014 for Young Scientists

We invite Heads of Research Institutions, Universities, Medical and Pharmaceutical Colleges of India to send in their nominations for the “Ranbaxy Science Scholar-2014”, research scholarship Awards for Young Scientists.

23 September 2013

Require Country Manager in Ranbaxy - Based in New Delhi

Ranbaxy Laboratories Limited (Ranbaxy), India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy today has a presence in 23 of the top 25 pharmaceutical markets of the world. The Company has a global footprint in 46 countries, world-class manufacturing facilities in 7 countries and serves customers in over 125 countries.

28 August 2013

NONINVASIVE AMBULATORY BLOOD PRESSURE MONITORING AFTER ADMINISTRATION OF ACE-INHIBITOR/CCB AND THEIR COMBINATION

ABOUT AUTHORS:
S.M Abdullah¹*, M Tandon¹, N Saha², K K Pillai³
¹M.Pharm, Department of Clinical Pharmacology Unit, Ranbaxy Laboratories Ltd, India.
²Department of Medical Affairs & Clinical Research, Ranbaxy Laboratories Ltd, India.
³Ph.D, Department of Pharmacology, Faculty of Pharmacy, Jamia Hamdard, India.

SUMMARY
The principle for the treatment of hypertension as per JNC-7 guideline is ‘treat to blood pressure (BP) <140/90 mmHg’ but in common clinical practice it is often difficult to lower the BP below 140/90 mmHg with monotherapy. While majority of patients requires two or more drugs to achieve target BP, this finally calls for comparative clinical evaluation of antihypertensive drugs as co-administration verses monotherapy.

METHOD: This study was randomized, single-blind, double-dummy, three-treatment, crossover study includednewly diagnosed treatment naive essential hypertensive patients; aged 20-45 years with sitting office BP ranged 140-159/94-104 mmHg. After 4 weeks of regular measurements of BP, all subjects received each treatment in randomized order for 1 week: imidapril 5 mg and placebo (I/P), lercanidipine 10 mg and placebo (L/P) or imidapril 5 mg and lercanidipine 10 mg (I/L). Prior to dosing and at the end of each treatment period, 24-hours ambulatory blood pressure monitoring (ABPM) was performed. Recorded data was analyzed for the evaluation of pharmacodynamic potential of each treatment.Beside this time-effect profile was also evaluated in terms of trough-to-peak (T/P) ratio.

24 August 2012

Urgent requirement in RANBAXY for Medical Representative in ADILABAD, BOBBILI, NARSARAOPETA, HQs

FOR MEDICAL REPRESENTATIVE JOBS *URGENT REQUIREMENT IN ‘RANBAXY MAXXIM’ FOR ADILABAD, NARSARAOPETA, BOBBILI HQS .

Post: TERRITORY EXECUTIVE

27 April 2012

Multiple vacancies in Ranbaxy | Require QC/QA Officers, Research Scientists, Production Officers - Fresher/Exp

Ranbaxy Laboratories Limited (Ranbaxy), India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy today has a presence in 23 of the top 25 pharmaceutical markets of the world.

18 January 2012

RANBAXY invites applications through WALK IN INTERVIEW for the posts of Front Line Sales Professionals

Ranbaxy, India's largest pharmaceutical company having a presence in Anti Infective, Respiratory, Pain Management, Derma, Ortho, Intensive Care, CNS, Oncology, Nephrology, HIV, CV, Urology and Gastro segments in India.
As a part of the expansion drive and ongoing requirements we are looking for young, dynamic and committed Front Line Sales Professionals in Mumbai and rest of Maharashtra.

Search

MITOMYCIN C: A USEFUL ANTICANCER DRUG

Search this website

Subscribe with us

Recent Posts

Jobs by Category

Jobs by Qualification